It is well accepted that aberrant mitochondrial function and dynamics are the hallmarks of numerous neurodegenerative disorders and more specifically, loss of function mutations in the catalytic C-terminus domain of PINK1, have been causally associated with early onset Parkinson’s disease (PD)2–4. This evidence concerns the gene PINK1 and Parkinson disease.